Silverarc Capital Management as of Dec. 31, 2024
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 61 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 6.8 | $31M | 400k | 78.28 | |
| Merus N V (MRUS) | 6.3 | $29M | 681k | 42.05 | |
| Insmed Com Par $.01 (INSM) | 5.6 | $26M | 372k | 69.04 | |
| Verona Pharma Sponsored Ads (VRNA) | 5.2 | $24M | 516k | 46.44 | |
| Akero Therapeutics (AKRO) | 4.5 | $21M | 740k | 27.82 | |
| Veracyte (VCYT) | 4.4 | $20M | 503k | 39.60 | |
| Erasca (ERAS) | 4.1 | $19M | 7.5M | 2.51 | |
| Pliant Therapeutics (PLRX) | 3.8 | $17M | 1.3M | 13.17 | |
| Syndax Pharmaceuticals (SNDX) | 3.6 | $16M | 1.2M | 13.22 | |
| Avidity Biosciences Ord (RNA) | 3.5 | $16M | 544k | 29.08 | |
| Rhythm Pharmaceuticals (RYTM) | 3.4 | $15M | 274k | 55.98 | |
| Intra Cellular Therapies (ITCI) | 3.3 | $15M | 179k | 83.52 | |
| Urogen Pharma (URGN) | 2.6 | $12M | 1.1M | 10.65 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.2 | $10M | 599k | 16.75 | |
| Kodiak Sciences (KOD) | 2.2 | $10M | 1.0M | 9.95 | |
| Poseida Therapeutics I (PSTX) | 2.1 | $9.7M | 1.0M | 9.60 | |
| Oric Pharmaceuticals (ORIC) | 2.1 | $9.5M | 1.2M | 8.07 | |
| Tela Bio (TELA) | 2.0 | $9.3M | 3.1M | 3.02 | |
| Scholar Rock Hldg Corp (SRRK) | 1.7 | $7.9M | 183k | 43.22 | |
| Wave Life Sciences SHS (WVE) | 1.6 | $7.5M | 609k | 12.37 | |
| Cogent Biosciences (COGT) | 1.6 | $7.2M | 921k | 7.80 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.6 | $7.1M | 52k | 137.67 | |
| Disc Medicine (IRON) | 1.5 | $7.0M | 110k | 63.40 | |
| Celldex Therapeutics Com New (CLDX) | 1.5 | $6.7M | 265k | 25.27 | |
| Elutia Cl A Com (ELUT) | 1.5 | $6.7M | 1.8M | 3.74 | |
| Biodesix | 1.4 | $6.6M | 4.3M | 1.53 | |
| Akero Therapeutics Call Call Option | 1.3 | $6.1M | 220k | 27.82 | |
| Gossamer Bio (GOSS) | 1.2 | $5.6M | 6.2M | 0.90 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.2 | $5.6M | 73k | 76.96 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.2 | $5.4M | 513k | 10.50 | |
| Ultragenyx Pharmaceutical (RARE) | 1.1 | $5.2M | 124k | 42.07 | |
| Kalvista Pharmaceuticals (KALV) | 1.1 | $5.2M | 612k | 8.47 | |
| Travere Therapeutics (TVTX) | 1.1 | $4.8M | 277k | 17.42 | |
| C4 Therapeutics Com Stk (CCCC) | 1.0 | $4.4M | 1.2M | 3.60 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.9 | $4.1M | 152k | 27.12 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $3.7M | 66k | 55.37 | |
| Incyte Corporation (INCY) | 0.7 | $3.4M | 49k | 69.07 | |
| Vaxcyte (PCVX) | 0.7 | $3.3M | 41k | 81.86 | |
| Geron Corporation (GERN) | 0.7 | $3.3M | 920k | 3.54 | |
| Trevi Therapeutics (TRVI) | 0.7 | $3.0M | 734k | 4.12 | |
| Compugen Ord (CGEN) | 0.5 | $2.5M | 1.6M | 1.53 | |
| Cerus Corporation (CERS) | 0.5 | $2.4M | 1.6M | 1.54 | |
| Syndax Pharmaceuticals Call Call Option | 0.5 | $2.3M | 172k | 13.22 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.5 | $2.1M | 285k | 7.32 | |
| Unicycive Therapeutics | 0.4 | $2.0M | 2.5M | 0.79 | |
| Miragen Therapeutics (VRDN) | 0.4 | $1.9M | 100k | 19.17 | |
| Delcath Sys Com New (DCTH) | 0.4 | $1.9M | 155k | 12.04 | |
| Uniqure Nv SHS (QURE) | 0.4 | $1.8M | 100k | 17.66 | |
| Modular Med Com New (MODD) | 0.4 | $1.7M | 1.3M | 1.37 | |
| Kala Bio Com New (KALA) | 0.4 | $1.6M | 231k | 6.94 | |
| Neumora Therapeutics Call Call Option | 0.3 | $1.6M | 147k | 10.60 | |
| Olema Pharmaceuticals (OLMA) | 0.3 | $1.4M | 233k | 5.83 | |
| Gilead Sciences (GILD) | 0.2 | $924k | 10k | 92.37 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $904k | 121k | 7.45 | |
| Radiopharm Theranostics Sponsored Ads (RADX) | 0.2 | $842k | 187k | 4.49 | |
| 89bio (ETNB) | 0.2 | $755k | 97k | 7.82 | |
| Vaxart Com New (VXRT) | 0.2 | $714k | 1.1M | 0.66 | |
| Karyopharm Therapeutics | 0.1 | $403k | 596k | 0.68 | |
| Fractyl Health (GUTS) | 0.1 | $365k | 177k | 2.06 | |
| Bioage Labs (BIOA) | 0.1 | $231k | 40k | 5.79 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $3.6k | 105k | 0.03 |